Sun starved Brits to risk health this summer
Following some of the coldest and wettest weather on record, around 4.9 million people in the UK (10 per cent) are more likely to risk scorching themselves in strong sun in an attempt to get a tan this summer, ...
Cancer
Apr 29, 2013 |
1 / 5 (1) |
1
Pediatric melanomas are increasing two percent a year
(HealthDay)—The incidence of pediatric melanoma has increased by about 2 percent per year, and this incidence trend is influenced by gender, age, and stage at diagnosis, primary site, and ultraviolet (UV)-B ...
Pediatrics
Apr 16, 2013 |
not rated yet |
0
Immortality gene mutation identifies brain tumors, other cancers
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research ...
Cancer
Mar 18, 2013 |
5 / 5 (3) |
0
|
Tapeworm DNA contains drug weak spots
For the first time, researchers have mapped the genomes of tapeworms to reveal potential drug targets on which existing drugs could act. The genomes provide a new resource that offers faster ways to develop urgently needed ...
Diseases, Conditions, Syndromes
Mar 13, 2013 |
5 / 5 (2) |
0
|
BRAF inhibitor treatment causes melanoma cells to shift how they produce energy
A multi-institutional study has revealed that BRAF-positive metastatic malignant melanomas develop resistance to treatment with drugs targeting the BRAF/MEK growth pathway through a major change in metabolism. The findings, ...
Cancer
Mar 08, 2013 |
5 / 5 (3) |
0
|
First evidence that obesity gene is risk factor for melanoma
The gene most strongly linked to obesity and overeating may also increase the risk of malignant melanoma – the most deadly skin cancer, reveals research published in Nature Genetics.
Genetics
Mar 04, 2013 |
5 / 5 (1) |
0
|
Sunbed users are twice as likely to use anti-ageing products as non-sunbed users
Over two fifths (43 per cent) of people in the UK who have used sunbeds – which are proven to prematurely age the skin – are using anti-ageing products. This compares with only a fifth (20 per cent) ...
Cancer
Feb 21, 2013 |
not rated yet |
0
Early results show two drugs may be better than one to treat most deadly skin cancer
Adding lung cancer drugs to targeted melanoma treatment could increase survival for certain patients, according to research published in Cancer Discovery today.
Cancer
Feb 12, 2013 |
not rated yet |
0
|
Steroids help reverse rapid bone loss tied to rib fractures
New research in animals triggered by a combination of serendipity and counterintuitive thinking could point the way to treating fractures caused by rapid bone loss in people, including patients with metastatic ...
Medical research
Feb 05, 2013 |
5 / 5 (1) |
0
|
New mutations driving malignant melanoma discovered
Two new mutations that collectively occur in 71 percent of malignant melanoma tumors have been discovered in what scientists call the "dark matter" of the cancer genome, where cancer-related mutations haven't ...
Cancer
Jan 24, 2013 |
not rated yet |
0
|
Sunbed skin cancer risk double that of Mediterranean midday summer sun
(Medical Xpress)—The average skin cancer risk from sunbeds is more than double that of spending the same length of time in the Mediterranean midday summer sun – according to new research from the University ...
Cancer
Jan 17, 2013 |
not rated yet |
0
|
Revolutionary techniques could help harness patients' own immune cells to fight disease
The human body contains immune cells programmed to fight cancer and viral infections, but they often have short lifespans and are not numerous enough to overcome attacks by particularly aggressive malignancies ...
Medical research
Jan 03, 2013 |
5 / 5 (4) |
0
|
Cocktail boosts immune cells in fighting cancer
Natural killer cells, as part of the body´s immune system, can effectively fight cancer. Unfortunately, they quickly lose their aggressiveness and hence are unable to reject solid tumors. Scientists from the German Cancer ...
Cancer
Dec 06, 2012 |
not rated yet |
0
|
New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
A newly developed antibody targeting a signalling pathway that is frequently active in solid tumours has shown encouraging signs of efficacy in its first trial in humans, researchers will report at the 24th EORTC-NCI-AACR ...
Cancer
Nov 06, 2012 |
5 / 5 (2) |
0
Recent findings may help to fight melanoma's resistance to chemotherapy
Blocking the action of a particular protein in our skin could improve the treatment of skin cancers, according to a study published in Oncogene yesterday by Philippe Roux, a researcher at the University of Montreal's Instit ...
Cancer
Oct 31, 2012 |
1 / 5 (1) |
0
